Nanomedicine News

RSS

Researchers Develop Breathanalyzers Using Nanometer-Thick Films for Testing Blood Sugar

Finger pricks may soon be a thing of the past for diabetics. Researchers at Western New England University have created a breathalyzer that may help control blood sugar by measuring the amount of acetone in the breath.

28 Nov 2013

Potential New Applications for BIND’s Medicinal Nanoengineering Platform

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that the company’s co-founders have published data demonstrating the successful engineering of targeted nanoparticles to cross biological barriers, such as the intestinal barrier, and enter the bloodstream, potentially broadening future therapeutic applications for BIND’s Medicinal Nanoengineering platform.

28 Nov 2013

BWH and MIT Researchers Develop Method to Administer Nanoparticle Therapeutics Orally

Pop a pill or be poked by a needle? Being able to orally deliver microscopic particles—know as nanoparticles—loaded with medicine is a simple, convenient way to treat patients for various diseases, such as cancer or diabetes.

28 Nov 2013

Merrimack to Develop Specialty Pharmaceuticals for Actavis Using its Nanotechnology Platform

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, and Actavis plc, a global, integrated specialty pharmaceutical company, today announced that the companies have entered into a collaboration agreement.

27 Nov 2013

New Microsystem to Test Drugs for Cystic Fibrosis and Epilepsy Treatment

Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.

27 Nov 2013

Nanotherapeutics Announces Conclusion of Type C Meeting with the US FDA

Nanotherapeutics, Inc. announced today that on November 20, 2013, the Company held a Type C meeting with the U.S. Food and Drug Administration (“FDA”), providing an opportunity for the FDA to review and provide feedback on Nanotherapeutics’ plans for its Advanced Development and Manufacturing (NANO-ADM) Center facility to be located in Copeland Park, Alachua, FL.

From Nanotherapeutics Inc. 25 Nov 2013

Positive CHMP Opinion on ABRAXANE with Gemcitabine for Metastatic Pancreatic Cancer Treatment

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency’s (EMA): Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Researchers Develop Nanotherapeutic Capable of Penetrating Blood-Brain Barrier

The University of Delaware’s Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.

25 Nov 2013

UB’s Paras Prasad Earns Honorary Doctorate for His Pioneering Work in Biophotonics

UB faculty member Paras Prasad has received an honorary doctorate from the Royal Institute of Technology in Sweden (KTH) for his pioneering work in areas including the use of light-based technologies to address important, global health problems.

25 Nov 2013

Naturally Occurring Nano-Material Within Cells May Lead to Engineered Bio-Composites for Drug Delivery

A team of researchers has uncovered critical information that could help scientists understand how protein polymers interact with other self-assembling biopolymers. The research helps explain naturally occurring nano-material within cells and could one day lead to engineered bio-composites for drug delivery, artificial tissue, bio-sensing, or cancer diagnosis.

22 Nov 2013

Nanomedicine News

Researchers Develop Breathanalyzers Using Nanometer-Thick Films for Testing Blood Sugar

Potential New Applications for BIND’s Medicinal Nanoengineering Platform

BWH and MIT Researchers Develop Method to Administer Nanoparticle Therapeutics Orally

Merrimack to Develop Specialty Pharmaceuticals for Actavis Using its Nanotechnology Platform

New Microsystem to Test Drugs for Cystic Fibrosis and Epilepsy Treatment

Nanotherapeutics Announces Conclusion of Type C Meeting with the US FDA

Positive CHMP Opinion on ABRAXANE with Gemcitabine for Metastatic Pancreatic Cancer Treatment

Researchers Develop Nanotherapeutic Capable of Penetrating Blood-Brain Barrier

UB’s Paras Prasad Earns Honorary Doctorate for His Pioneering Work in Biophotonics

Naturally Occurring Nano-Material Within Cells May Lead to Engineered Bio-Composites for Drug Delivery

Enhancing Material Properties through Nanotube Encapsulation

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials